- 询价
- Immunoway
- YM6672
- 2025年07月14日
- WB;ELISA
- 小鼠
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
Mouse, Monoclonal/IgG1, Kappa
- 形态：
液体
- 保存条件：
-20
- 克隆性：
单克隆
- 适应物种：
Human
- 保质期：
一年
- 级别：
病理级
- 库存：
100
- 供应商：
ImmunoWay Biotechnology Company
- 宿主：
小鼠
- 应用范围：
WB;ELISA
- 靶点：
TGF β Receptor II
- 规格：
40uL/100ul/200ul
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验11 Detection of TGF Type II Receptor Hotspot Mutations: The BAT-RII Assay
in the TGF-β pathway detected thus far is mutation of the type II receptor (RII) in colon cancers, particularly in tumors with defective mismatch repair or microsatellite instability (MSI) (3 –5 ). These RII mutations occur in a repetitive region of coding
Characterization of SMAD Phosphorylation and SMAD/Receptor Interaction
Signaling by transforming growth factor-(β superfamily members is initiated when ligand binds to and induces formation of a heteromeric receptor complex composed of type I and type II serine/threonine kinase receptors (reviewed in refs. 1 –
encephalomyelitis (EAE)—a model of multiple sclerosis (MS), collagen II (CII)-induced arthritis (CIA)—a model of rheumatoid arthritis (RA). Pathogenic T cells in EAE utilize a restricted repertoire of genes encoding the T-cell receptor (TCR) (1 ). For example
技术资料暂无技术资料 索取技术资料
